This job has expired

You will need to login before you can apply for a job.

Senior Medical Director, Drug Safety and Pharmacovigilance

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Nov 10, 2023

View more

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How you will Achieve More with Intellia:

We are excited to welcome this new member to our growing team and company. This is both a strategic and hands-on role. If you are a strong problem-solver, agile with detailed regulations and requirements for global safety surveillance & safety risk management and enjoy cross-functional partnerships, this is the role for you! As the Medical Safety Lead, you will lead and work on various projects including but not limited to:

  • Develop strategy for Safety surveillance for the clinical trials across platform in collaboration with clinical development team
  • Manage safety signals and lead cross-functional safety management team
  • Lead DSPV in various cross-functional teams (e.g., Clinical program teams)
  • Perform medical review of SAEs, SUSARs and aggregate safety data from all sources in collaboration with CRO medical monitors
  • Lead the development of safety risk management plans, IND annual safety reports
  • Develop and update RSIs for IBs
  • Develop and contribute for BLA safety deliverables and regulatory responses
  • Develop and contribute for safety surveillance SOPs, participate in PV audit and inspections
  • Collaborate with PV Operation on DSPV functional deliverables
  • Supervise, coach and mentor safety/risk management scientists

About You:

You are an experienced safety physician (MD) with solid clinical experience from direct patient care (clinical experience in Oncology or Immunology preferred) and 10+ years of experience in drug safety and pharmacovigilance. You are to lead and work in a fast paced, growing drug safety & pharmacovigilance department where your knowledge and hands-on experience of the good pharmacovigilance practices and international regulatory requirements such as EMA/FDA/ICH guidelines will contribute to establish a state-of-the-art safety surveillance team. You have prior experience in leading and authoring safety sections of IND or BLA submission dossiers. You are intrigued by the new challenges to pharmacovigilance that accompanies novel gene editing therapies. Your prior experience with gene therapy products or biologics and advanced degree in epidemiology will be plus. On a product/program team, you work collectively with all relevant functions for DSPV including medical, clinical operations, data management, biostatics, regulatory, quality and manufacturing.

Meet your future team:

Intellia strives to form an experienced, patient-focused drug safety & pharmacovigilance (DSPV) function. The present team is comprised of a small team of experienced PV professionals including Safety physician, safety scientist, PV operations lead and the functional head. Plans are in place to build a team of knowledgeable and conscientious pharmacovigilance professionals to support our growing portfolio.

Covid-19 Vaccination Policy:All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Telephone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert